Document is current

Article History

Received: 12 November 2021

Accepted: 19 April 2022

First Online: 9 May 2022

Declarations

:

: Fabienne Englmeier and Klaus Nagels have received payments from Roche Pharma AG to their institution during the conduct of the study. Klaus Nagels reports personal fees from Amgen, Lilly, Roche, Novartis, outside the submitted work; Annalen Bleckmann reports personal fees from Alexion, Gilead, Novartis, BMS, Bayer, Servier, Roche, AstraZeneca, Takeda, Merck, Boehringer Ingelheim, Lilly Pharma, Abbvie, BeiGene outside the submitted work. Annalen Bleckmann participated on the Roche Advisory Board outside the submitted work; Wolfgang Brueckl reports personal fees from Astra Zeneca, BMS, Boehringer Ingelheim, MSD, Lilly Pharma, Pfizer, Roche, Chugai, Takeda, Novartis, outside the submitted work; Wolfgang Brueckl participated on several Advisory Boards (AstraZeneca, Boehringer Ingelheim, Novartis, MSD, Lilly Pharma, BMS, Roche), outside the submitted work. Frank Griesinger reports grants to the institution from AstraZeneca, Boehringer Ingelheim, BMS, Lilly Pharma, MSD, Novartis, Pfizer, Roche, Takeda, Siemens, AMGEN, GSK, Johnson & Johnson, outside the submitted work. Frank Griesinger reports personal fees from Advisory Board Roche, Boehringer Ingelheim, Takeda, Abbvie, AstraZeneca, MSD, Pfizer, Sobi, Merck, Bristol-Myers Squibb, Janssen-Cilag, AMGEN, Ipsen, Novartis, outside the submitted work. Frank Griesinger participated on several Advisory Boards (Roche, Boehringer Ingelheim, Takeda, Abbvie, AstraZeneca, MSD, Pfizer, Sobi, Merck, Bristol-Myers Squibb, Janssen-Cilag, AMGEN, Ipsen, Novartis), outside the submitted work. Annette Fleitz declares that she has no conflicts of interests.